ARNA - Arena Pharmaceuticals

Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ

ARNA - Arena Pharmaceuticals

Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ

Tue 31'st Jul 2018

PERIOD 2018-05-02 - 2018-07-31
CHANGE 0.70%
PRICE $38.59






Arena Pharmaceuticals Stock Analysis

Technical stock analysis for Tue 31'st Jul 2018

Sell candidate since 2018-07-23 Loss -11.85%
Shorts 5.23% ( 2018-07-13 )
Cash 409.5 mill
Loans 126.3 mill
Beta 1.53
ROA n/a

Arena Pharmaceuticals gained 0.70% in the last trading day, rising from $38.32 to $38.59 The price has fallen in 8 of the last 10 days and is down by -13.42% for this period. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 55 541 more shares were traded than the day before. In total, 592 780 shares bought and sold for approximately $22.88 million.


Arena Pharmaceuticals lies in the lower of a very wide and falling trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at $38.27 will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -6.58% during the next 3 months and, with 90% probability hold a price between $35.75 and $44.74 at the end of this period.

Click here for today's Top 5 Trending Companies


A buy signal was issued from a pivot bottom point on Monday July 30, 2018, which indicates further gains until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Arena Pharmaceuticals holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $40.18 and $44.25. A break-up above any of these levels will issue buy signals.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

The stock currently holds a RSI14 at 21 and is oversold on RSI14. The stock being oversold is no guarantee for instant reaction up as some stocks may be oversold for a long time. It is important to review the previous RSI-history to get an indication of the RSI-sensitiveness.

Access full RSI 14 and RSI 21 lists

Support & Resistance

Arena Pharmaceuticals finds support from accumulated volume at $38.46.

Support: $38.46 Price: $38.59 Resistance: $41.97


This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.71 between high and low, or 1.86%. For the last week, the stock has had a daily average volatility of 3.36%.

Arena Pharmaceuticals is oversold on RSI14 (21). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High


Arena Pharmaceuticals holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our recommendation for this stock since last evaluation from a Strong Sell Candidate to a Sell Candidate.

Sell Candidate

Click for Top 5 Sell Candidates

Hot Trends

what is the current price of walmart stock should you buy apple stock now top short stocks netflix stock how to buy prudential stock index fb stock stock is it a good time to buy netflix stock starbucks coffee stock price today ge stock buy or sell ge stock outlook can you invest in tesla why is tesla down today stocks to sell what is sbux nike stock investment wmt stock price history chk stock predictions

Last donation

Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features

Proudly made at

in partnership with